About the Vision Academy

Our mission statement

The Vision Academy provides ophthalmic specialists with a forum to share existing skills and knowledge, provide consensus guidance for managing clinically challenging situations, and lead the wider community in the drive toward optimized, compassionate patient care.

The Vision Academy is Co-Chaired by Professors Jean-François Korobelnik and Anat Loewenstein. Hear more about the Vision Academy from Professor Loewenstein in the video below.

About the Vision Academy

YYMMDD Author/Uploaded by
Bayer Logo Bayer Logo Bayer Logo Bayer Logo

The Vision Academy comprises an international group of more than 100 experts worldwide.

Through their collective expertise, the Vision Academy seeks to provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence.

MEET THE MEMBERS

Challenging clinical situations

Disease insights, diagnosis, and monitoring

Disease insights, diagnosis, and monitoring

Providing care that considers the individual patient’s preferences and needs should be at the forefront of clinical decision-making. The ophthalmic community should be driven by patient values, with the patient placed centrally in the treatment decision pathway. Nonetheless, there are many disease complexities that require nuanced treatment and management. We aim to provide guidance that enables ophthalmologists to navigate these clinically challenging situations.

VIEW THE WORKSTREAMS

Treatment and management

Treatment and management

Providing care that considers the individual patient’s preferences and needs should be at the forefront of clinical decision-making. The ophthalmic community should be driven by patient values, with the patient placed centrally in the treatment decision pathway. Nonetheless, there are many disease complexities that require nuanced treatment and management. We aim to provide guidance that enables ophthalmologists to navigate these clinically challenging situations.

VIEW THE WORKSTREAMS

COVID-19

COVID-19

The lasting impacts of the COVID-19 pandemic have resulted in ongoing changes to clinical practice. We, in conjunction with the nAMD Barometer, have developed a range of materials to ensure ophthalmologists feel supported in making appropriate treatment decisions and to help patients better understand the safety measures put in place. These tools have been designed to be appropriate across a range of epidemic pressures and are available in multiple languages.

VIEW THE RESOURCES

Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Resource zone

The Vision Academy has a vast selection of useful materials, all of which are freely available to use.

GO TO THE LIBRARY